7-Keto-Dehydroepiandrosterone Adenosine Triphospha

證據等級: L5

預測適應症: 0 個

Multi-Ingredient Homeopathic Complex: Insufficient Data for Repurposing Evaluation

One-Sentence Summary

This candidate consists of a 16-component mixture including homeopathic ingredients, organ extracts, botanical materials, and conventional molecules (e.g., Insulin Human, Methylcobalamin). The composition does not correspond to a single drug entity recognised in standard pharmacological databases, and TxGNN returned no predicted indications. As a result, a standard drug repurposing evaluation cannot be completed at this time.

Quick Overview

Item	Content
Original Indication	None on record
Predicted New Indication	None (no TxGNN output)
TxGNN Prediction Score	N/A
Evidence Level	L5 — model prediction only (no output produced)
US Market Status	Not marketed
Number of NDAs	0
Recommended Decision	Hold

Why This Prediction Is Not Available

The candidate identifier resolves to a 16-ingredient mixture rather than a single active pharmaceutical ingredient:

#	Ingredient	Category
1	7-Keto-Dehydroepiandrosterone	Endogenous steroid metabolite
2	Adenosine Triphosphate Disodium	Nucleotide / energy substrate
3	Echinacea, unspecified	Botanical immunomodulator
4	Gamboge	Resin / traditional cathartic
5	Graphite	Homeopathic mineral
6	Insulin Human	Peptide hormone
7	Lactic Acid, L-	Organic acid
8	Methylcobalamin	Vitamin B12 analogue
9	Phytolacca americana Root	Homeopathic botanical
10	Pork Kidney	Animal organ extract
11	Pork Liver	Animal organ extract
12	Proteus vulgaris	Homeopathic nosode (bacteria)
13	Strychnos nux-vomica Seed	Homeopathic botanical (alkaloid source)
14	Sus scrofa Hypothalamus	Porcine organ extract
15	Sus scrofa Pancreas	Porcine organ extract
16	Vincetoxicum hirundinaria Root	Homeopathic botanical

TxGNN is designed to operate on single drug–disease pairs anchored to a DrugBank ID. Because this candidate has no DrugBank ID and is not a unified molecular entity, the model produced no output. Mechanism-of-action analysis is similarly not possible for the mixture as a whole.

Safety Considerations

Please refer to individual ingredient package inserts or regulatory submissions for safety information.

⚠️ Special note: This mixture contains Insulin Human, a high-alert medication with serious hypoglycaemia risk, and Strychnos nux-vomica (source of strychnine), which carries a narrow therapeutic index. Any formulation containing these ingredients requires rigorous dose and safety documentation regardless of the overall product classification.

Conclusion and Next Steps

Decision: Hold

Rationale: The candidate cannot be evaluated as a drug repurposing candidate because it is a heterogeneous multi-ingredient mixture with no unified pharmacological identity, no DrugBank mapping, no regulatory authorisation, and no TxGNN prediction output.

To proceed, the following is needed:

Clarify the evaluable unit — Identify which single active ingredient within the mixture is the intended repurposing target (e.g., 7-Keto-DHEA or Methylcobalamin independently).
Obtain DrugBank ID for that single ingredient and re-submit to the TxGNN pipeline.
Determine product classification — Confirm whether this is a registered homeopathic product, a dietary supplement, or a compounded formulation, as this affects the regulatory pathway.
Obtain full ingredient-level safety data — particularly for Insulin Human (hypoglycaemia) and Strychnos nux-vomica (strychnine toxicity) components.
Re-run Evidence Pack generation on the individual active ingredient once identified.
Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.